CVS Health (NYSE:CVS) Upgraded to “Strong-Buy” at Leerink Partnrs

CVS Health (NYSE:CVS) was upgraded by investment analysts at Leerink Partnrs from a “hold” rating to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s FY2027 earnings at $8.23 EPS and FY2028 earnings at $9.36 EPS.

A number of other analysts also recently weighed in on the company. Piper Sandler dropped their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Cantor Fitzgerald upgraded CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday. Wolfe Research boosted their target price on CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research report on Tuesday. UBS Group dropped their target price on CVS Health from $62.00 to $59.00 and set a “neutral” rating for the company in a research report on Tuesday. Finally, Leerink Partners upgraded CVS Health from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $55.00 to $75.00 in a research report on Thursday. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $70.28.

CVS Health Stock Up 4.9 %

Shares of NYSE CVS opened at $66.35 on Wednesday. CVS Health has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $83.49 billion, a price-to-earnings ratio of 16.84, a PEG ratio of 0.60 and a beta of 0.61. The business has a 50-day moving average of $50.71 and a 200-day moving average of $55.94.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. Sell-side analysts expect that CVS Health will post 5.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On CVS Health

Several hedge funds have recently made changes to their positions in the business. Integrated Advisors Network LLC increased its stake in shares of CVS Health by 0.7% during the third quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator’s stock valued at $1,737,000 after buying an additional 200 shares during the period. Widmann Financial Services Inc. increased its stake in shares of CVS Health by 1.8% during the third quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator’s stock valued at $724,000 after buying an additional 200 shares during the period. EagleClaw Capital Managment LLC increased its stake in shares of CVS Health by 3.4% during the fourth quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator’s stock valued at $275,000 after buying an additional 200 shares during the period. DT Investment Partners LLC increased its stake in shares of CVS Health by 7.8% during the third quarter. DT Investment Partners LLC now owns 2,777 shares of the pharmacy operator’s stock valued at $175,000 after buying an additional 202 shares during the period. Finally, Manchester Capital Management LLC grew its stake in CVS Health by 4.8% in the fourth quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator’s stock worth $200,000 after purchasing an additional 204 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.